BCM Advisors’s Medtronic MDT Stock Holding History

BCM Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-95	Closed	-$7K	–	66
2016 Q4	$7K	Buy	+95	New	+$7.46K	﹤0.01%	90

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BCM Advisors's MDT Position: Q1 2017 in Review

BCM Advisors sold out of Medtronic (MDT) in Q1 2017, closing a stake of 95 shares — an estimated $7K sold.

BCM Advisors first reported a position in MDT in Q4 2016 and held it in 1 quarter. The position peaked at $7K in Q4 2016. 1,283 funds tracked by Wall St. Rank hold MDT as of Q1 2017.

BCM Advisors reported no remaining Medtronic position as of Q1 2017 after selling out during the quarter.
BCM Advisors sold 95 Medtronic shares in Q1 2017, an estimated $7K.
BCM Advisors first reported a position in Medtronic in Q4 2016 and held it in 1 quarter.
BCM Advisors's Medtronic position peaked at $7K in Q4 2016.
1,283 funds tracked by Wall St. Rank held Medtronic as of Q1 2017.

Based on BCM Advisors's 13F filing for Q1 2017, filed 12 May 2017.